Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
As we continue to battle the COVID-19 pandemic, we must confront the possibility of new pathogenic coronaviruses emerging in humans in the future. With this in mind, Rappazzo et al. isolated antibodies from a survivor of the 2003 severe acute respiratory syndrome coronavirus (SARS-CoV), used yeast d...
Saved in:
Published in | Science (American Association for the Advancement of Science) Vol. 371; no. 6531; pp. 823 - 829 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The American Association for the Advancement of Science
19.02.2021
American Association for the Advancement of Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!